National Research (NASDAQ:NRC) Shares Pass Above 200 Day Moving Average – Time to Sell?

National Research Corporation (NASDAQ:NRC)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.77 and traded as high as $15.92. National Research shares last traded at $14.97, with a volume of 264,927 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded National Research from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday. One analyst has rated the stock with a Sell rating, According to MarketBeat, National Research has a consensus rating of “Sell”.

National Research Price Performance

The firm has a market capitalization of $339.22 million, a P/E ratio of 29.94 and a beta of 0.53. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 5.36. The firm has a 50 day moving average price of $17.07 and a 200-day moving average price of $15.77.

National Research (NASDAQ:NRC) last released its earnings results on Tuesday, February 3rd. The company reported $0.16 earnings per share for the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.The firm had revenue of $35.19 million for the quarter.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Shareholders of record on Friday, March 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 4.3%. National Research’s payout ratio is 128.00%.

Institutional Investors Weigh In On National Research

Several institutional investors have recently made changes to their positions in NRC. DGS Capital Management LLC purchased a new position in shares of National Research during the 4th quarter worth about $274,000. Invesco Ltd. raised its position in National Research by 14.9% in the 4th quarter. Invesco Ltd. now owns 21,598 shares of the company’s stock worth $405,000 after purchasing an additional 2,799 shares during the period. Public Employees Retirement System of Ohio raised its position in National Research by 13.2% in the 4th quarter. Public Employees Retirement System of Ohio now owns 88,207 shares of the company’s stock worth $1,656,000 after purchasing an additional 10,312 shares during the period. Squarepoint Ops LLC bought a new stake in National Research in the fourth quarter worth about $311,000. Finally, Morgan Dempsey Capital Management LLC bought a new stake in National Research in the fourth quarter worth about $296,000. Institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.